CNS Drugs Optimizing Outcomes in Major Depressive Disorder via Augmentation Therapy - Focus on the Role of Atypical Antipsychotics

CNS Drugs - United Kingdom
doi 10.1007/s40263-013-0052-3
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC